Astral’s stock dipped 11% after announcing a demerger of its chemicals business. Investors are concerned about the valuation and growth prospects of the standalone chemical entity, which currently lags the profitable plumbing segment. While analysts maintain ‘buy’ ratings, some have lowered target prices. The company anticipates significant revenue growth for the chemicals division in the coming years.
Market veterans favour value plays over crowded, expensive themes
Market experts project cautious optimism for Indian equities as valuations become less demanding and earnings growth aligns. Large-cap stocks appear more favorable compared to mid-
September 29, 2026